2025 Revenue Reaches 4.71 Billion Won,
Up 101.5% Year-on-Year

Appclon has met the requirements for removal from the watchlist designation. As its annual revenue surpassed 3 billion won, which is the KOSDAQ threshold for watchlist designation, the company resolved the reason for being on the watchlist related to revenue requirements.

Appclon company logo image. Appclon

Appclon company logo image. Appclon

View original image

On January 30, Appclon disclosed its provisional standalone results for 2025 through a public announcement of ‘a change of 30% or more in sales or profit structure.’ Annual revenue reached 4,714.08 million won, up 101.5% year-on-year. This figure resolves the issue of ‘annual revenue below 3 billion won,’ which was the reason for its watchlist designation under KOSDAQ listing regulations. Appclon had been designated as a watchlist stock last year because its revenue did not exceed 3 billion won.


In this performance report, Appclon also improved its financial structure alongside revenue growth. As of the end of 2025, total assets stood at 70,746.51 million won, a significant increase from the previous year, while total liabilities decreased to 11,094.52 million won. Total equity expanded to 59,651.99 million won, more than doubling year-on-year.


However, the operating loss widened to 18,422.46 million won compared to the previous year. The company explained that the main reason was increased research and development expenses due to the ongoing Phase 2 clinical trial for its CAR-T (chimeric antigen receptor T) cell therapy.



The company also stated that, regarding the requirement for pre-tax loss from continuing operations?commonly referred to as the ‘pre-tax loss’ criterion?it has completed preparations to ensure compliance with regulations through capital expansion and improved financial structure.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing